Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule

Head and Neck

Volumn 34, Issue 7, 2012, Pages 949-952

  Moon, Seong Su ^a   Lee, Young Sil ^a   Lee, In Kyu ^b,c,d   Kim, Jung Guk ^b  

^a Dongguk University College of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d Kyungpook National University   (South Korea)

Author keywords

Euthyroid; Fine needle aspiration biopsy; Micronodule; Thyroid microcarcinoma; Thyroid stimulating hormone

Indexed keywords

THYROTROPIN;

ADULT; ARTICLE; CANCER RISK; FEMALE; HUMAN; HUMAN TISSUE; MALE; NODULAR HYPERPLASIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID MICROCARCINOMA; THYROID PAPILLARY CARCINOMA; THYROTROPIN BLOOD LEVEL;

CROSS-SECTIONAL STUDIES; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; THYROTROPIN;

EID: 84862834949     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21828     Document Type: Article

References (30)

1. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989;63: 908-911. (Pubitemid 19063200)
2. Sampson RJ, Key CR, Buncher CR, Iijima S. Thyroid carcinoma in Hiroshima and Nagasaki. I. Prevalence of thyroid carcinoma at autopsy. J Am Med Assoc 1969;209:65-70.
3. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 1985;56:531-538. (Pubitemid 15035581)
4. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies. Am J Clin Pathol 1988;90:72-76.
5. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-. J Am Med Assoc 2006;295:2164-2167.
6. Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 2008;144:980-988.
7. Leenhardt L, Grosclaude P, Cherie-Challine L. Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 2004;14:1056-1060. (Pubitemid 40076130)
8. Carmeci C, Jeffrey RB, McDougall IR, Nowels KW, Weigel RJ. Ultrasound- guided fine-needle aspiration biopsy of thyroid masses. Thyroid 1998;8:283-289. (Pubitemid 28198720)
9. Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid 1998;8:15-21. (Pubitemid 28082616)
10. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-1214.
11. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003;24: 102-132. (Pubitemid 36223282)
12. Haymart MR, Repplinger DJ, Leverson GE, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008;93:809-814. (Pubitemid 351398557)
13. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006;91:4295-4301. (Pubitemid 44833401)
14. Boelaert K. The association between serum TSH concentration and thyroid cancer. Endocr Relat Cancer 2009;16:1065-1072.
15. Jin J, Machekano R, McHenry CR. The utility of preoperative serum thyroid- stimulating hormone level for predicting malignant nodular thyroid disease. Am J Surg 2010;199:294-298.
16. Roger P, Taton M, Van Sande J, Dumont JE. Mitogenic effects of thyrotropin and adenosine 30,50-monophosphate in differentiated normal human thyroid cells in vitro. J Clin Endocrinol Metab 1988;66:1158-1165.
17. Derwahl M, Broecker M, Kraiem Z. Clinical review 101: thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. J Clin Endocrinol Metab 1999;84: 829-834.
18. Fiore E, Rago T, Provenzale MA, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 2009;16: 1251-1260.
19. Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC, Chen H. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol (Oxf) 2009;71: 434-439.
20. Gerschpacher M, Gobl C, Anderwald C, Gessl A, Krebs M. Thyrotropin serum concentrations in patients with papillary thyroid microcancers. Thyroid 2010;20:389-392.
21. Jang YY, Kim CY, Hwang TY, Kim KD, Lee CH. [Reference interval of serum thyroid hormones in healthy Korean adults]. J Prev Med Public Health 2008;41:128-134.
22. Bidey SP, Hill DJ, Eggo MC. Growth factors and goitrogenesis. J Endocrinol 1999;160:321-332. (Pubitemid 29182824)
23. Westermark K, Karlsson FA, Westermark B. Thyrotropin modulates EGF receptor function in porcine thyroid follicle cells. Mol Cell Endocrinol 1985;40:17-23. (Pubitemid 15113137)
24. Eggo MC, Bachrach LK, Burrow GN. Interaction of TSH, insulin and insulin-like growth factors in regulating thyroid growth and function. Growth Factors 1990;2:99-109. (Pubitemid 20057748)
25. Burikhanov R, Coulonval K, Pirson I, Lamy F, Dumont JE, Roger PP. Thyrotropin via cyclic AMP induces insulin receptor expression and insulin Co-stimulation of growth and amplifies insulin and insulin-like growth factor signaling pathways in dog thyroid epithelial cells. J Biol Chem 1996;271:29400-29406. (Pubitemid 26382658)
26. Hoelting T, Tezelman S, Siperstein AE, Duh QY, Clark OH. Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC-rather than PKA-activation. Biochem Biophys Res Commun 1993;195:1230-1236. (Pubitemid 23290286)
27. Brabant G, Maenhaut C, Kohrle J, et al. Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 1991;82:R7-R12.
28. Gul K, Ozdemir D, Dirikoc A, et al. Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin? Endocrine 2010;37:253-260.
29. Lim DJ, Baek KH, Lee YS, et al. Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma. Thyroid 2007;17: 883-888.
30. Lee J, Rhee Y, Lee S, et al. Frequent, aggressive behaviors of thyroid microcarcinomas in Korean patients. Endocr J 2006;53:627-632. (Pubitemid 44691014)